2026 Longevity & Wellness M&A Market Update: Investor Appetite Accelerates
Is Now the Right Time to Sell Your Longevity Wellness and Concierge Medicine Business?
Longevity, wellness, and concierge medicine present a compelling investment opportunity at the intersection of healthcare services and consumer spending. Longevity, wellness, and concierge medicine care delivery models appeal to patients seeking a more personalized and proactive approach to their health and have become very sought after in today’s environment.
Investment in longevity, wellness, and concierge medicine is still in the very early innings compared to other spaces within healthcare services but has increased rapidly over the last 12-18 months as investors continue to seek exposure to the rapid growth that has transpired within the category. Notable recent transactions include L Catterton’s reported acquisition of SignatureMD from Blue Sea Capital in early 2026 and Revelstoke Capital Partners’ investment in Griffin Concierge Medical in September 2025. PGP has spoken to a number of interested parties looking to invest in the sector and the common investment thesis is underpinned by strong tailwinds including an aging population with high prevalence rates of chronic disease, rising awareness for longevity modalities, and a strong consumer preference for more personalized care.
For founder-owned practices, a capital or strategic partnership can provide resources to scale more quickly than they could independently. A sale in today’s environment allows owners the ability to monetize their equity in a seller favorable market, while also retaining significant upside and economic participation to take advantage of the tailwinds driving demand in the sector.
What Is Driving Private Equity and Strategic Buyer Interest in Longevity, Wellness, and Concierge Medicine?
The wellness market has experienced rapid growth in recent years, and McKinsey estimates the global wellness market at approximately $2 trillion.1 Within the global wellness market, estimates suggest that the US medical weight loss market could be valued at approximately $30 billion with concierge and personalized care growing from $7.35 billion in 2024 to $13.23 billion by 2030, a 10.3% compound annual growth rate.2
Contrary to Medicare-focused categories within healthcare services, demand in the wellness and longevity space has skewed younger with Gen Z and Millennials accounting for 41% of wellness spending despite representing 36% of US adults.1
At the same time, the rapid proliferation of services has started to and will continue to attract regulatory attention. While the last five years have been characterized by rapid growth, Physician Growth Partners (PGP) expects regulatory oversight to intensify over the next five, though unevenly across modalities. In medical weight loss, enforcement has tightened sharply: with GLP-1 shortages resolved in 2025, the FDA announced in February 2026 that it would restrict GLP-1 active ingredients used in mass-marketed compounded products and has issued dozens of warning letters to telehealth companies over compounded GLP-1 marketing claims. By contrast, peptide therapies have moved toward greater access: in April 2026 the FDA removed a group of peptides, including BPC-157, from its Category 2 list, and in July 2026 its Pharmacy Compounding Advisory Committee recommended several for the 503A bulks list, although formal rulemaking remains pending. Formulation, dosing, ingredient sourcing, compounding, and marketing claims will remain the key areas of scrutiny, and buyers are increasingly diligencing the share of revenue tied to compounded products.3 4
What Are the Different Longevity, Wellness, and Concierge Medicine Care Delivery Models?
Although frequently grouped together, longevity, wellness, and concierge medicine have different economics and operating models. A clear definition of the business is essential to identifying relevant partners and positioning the opportunity effectively.
| Segment | Core offering | Revenue and valuation considerations |
|---|---|---|
| Concierge medicine | Personalized physician access, longer visits, care coordination, and preventive care | Membership growth and pricing, physician and patient retention, recurring revenue, ancillary services |
| Longevity medicine | Longitudinal preventive care, risk assessment, and healthspan programs that may include advanced diagnostics | Recurring engagement, clinical credibility, strong unit economics, brand strength, diversified service offering |
| Integrated practices | A coordinated combination of primary care, prevention, aesthetics and selected wellness services | Service integration, revenue diversity, consistent patient experience, and repeatable site economics |
Based on PGP’s experience and direct discussions, concierge practices offering membership and direct-pay models have gained traction, particularly with affluent patient populations that want access to premium diagnostics services, bio-optimization therapies, and continuous remote monitoring. The concierge model boasts shorter wait times, longer visit lengths, 24/7 access, and significantly smaller patient panels per physician than the traditional primary care model. Models span entirely subscription-based to hybrid (cash pay and reimbursed) to employer-based, corporate wellness platforms where employers offer on-site or virtual care delivery solutions in the workplace. Direct primary care (DPC), a lower-priced subscription model that generally does not bill insurance, gained a tailwind in 2026: beginning January 1, 2026, patients with high-deductible health plans may use HSA funds for DPC fees of up to $150 per month for individuals and $300 per month for families. Concierge models that charge a membership fee on top of insurance billing generally do not qualify, and buyers underwrite the two models differently.
Functional and longevity medicine is an important component of the longevity, wellness, and concierge medicine landscape as well, with services that span medical weight loss, personalized hormone therapy, anti-aging peptide therapy, NAD+ optimization, preventive diagnostics, nutrition and wellness services. Medical weight loss, personalized hormone therapy, anti-aging peptide therapy, NAD+ optimization, preventive diagnostics, nutrition and wellness services have seen tremendous growth but not without challenges as off-label use, lack of standardization, lack of physician training, and polarizing opinions from physicians may hinder broader adoption.
How Much Is My Longevity, Wellness, and Concierge Medicine Practice Worth?
In a sector characterized by fragmentation, there is significant scarcity value in operating a scaled business in the longevity space. Because of the scarcity value of scaled longevity businesses, investors are willing to apply a scale premium for businesses with a multilocation footprint and platform caliber infrastructure in place. PGP has had extensive discussions throughout the industry and has discovered that buyers typically evaluate mature, profitable businesses on adjusted EBITDA and pay higher multiples for businesses that exhibit many of the qualities outlined below:
What Drives the Value of a Longevity, Wellness, and Concierge Medicine Practice?
| Characteristic | Commentary |
|---|---|
| Recurring Revenue and Patient Retention | Membership renewals, cancellations, tenure, and revenue by patient cohort |
| Repeatable Growth Plan | Defined pathway for adding providers, expanding existing locations, and entering new markets |
| Provider Depth and Founder Independence | Ability to recruit and retain clinicians, transferability of the business and organization patient loyalty |
| Clinical Quality and Compliance | Documented protocols, appropriate prescribing, and credible patient communication support business durability |
| Brand and Revenue Diversity | Brand can support referrals and entry into new markets, but demand must extend beyond the founder’s personal following. |
Buyers will also test the quality of earnings behind recurring revenue, patient retention, repeatable growth, provider depth, founder independence, clinical quality, compliance, brand and revenue diversity. Prepaid annual memberships create deferred revenue that is typically treated as a liability in the working capital calculation, which can meaningfully affect closing proceeds if not addressed early in a process. Revenue tied to compounded medications, normalization of founder compensation, and the durability of cash-pay pricing are other common areas of focus. Owners preparing a sale should be able to report renewal rates, revenue per member, patient acquisition cost and payback, panel capacity utilization, and revenue per provider by location.
Who Is Buying Longevity, Wellness, and Concierge Medicine Groups Right Now?
•Private Equity-Backed Platforms: PE-backed platforms such as Griffin Concierge Medical, PeterMD and Agentis Longevity have developed a growth playbook predicated on aligning with businesses that share their clinical values and operating model. While selective in terms of who they align with, PE-backed platforms with shared resources can be very attractive partnership options for independent practices.
•Financial Buyers – Private Equity, Independent Sponsors, and Family Offices: Outside of traditional private equity firms that have invested in the sector, many patient capital providers like family offices and independent sponsors have developed a thesis in the space.
•Venture Capital: Given how nascent the segment is, venture funds have and will continue to invest in less established, tech-enabled businesses with strong growth prospects.
•Affiliation and Conversion Networks: Networks such as MDVIP and SignatureMD help independent physicians convert to a membership model in exchange for a share of membership revenue. Affiliation and conversion arrangements can provide operating support but generally do not deliver the upfront liquidity of a control or minority equity transaction, and owners should evaluate them accordingly.
•Health Systems and Consumer Health Companies: Health systems are increasingly launching or partnering on concierge programs, and well-capitalized consumer diagnostics and preventive health companies have begun acquiring complementary businesses, such as Function Health’s acquisitions of Ezra and SuppCo.
| Buyer | Sponsor | Category |
|---|---|---|
| Agentis Longevity | Shore Capital | Longevity |
| Novellum Longevity | Boyne Capital; Platt Park Capital | Longevity |
| Formula Wellness | Trive Capital | Longevity |
| Aligned Modern Health | Arcventis Health Partners | Longevity |
| Restore Hyper Wellness | General Atlantic | Longevity |
| Griffin Concierge Medical | Revelstoke Capital Partners | Concierge |
| MDVIP | Goldman Sachs; Charlesbank Capital Partners | Concierge |
| PeterMD | Lorient Capital | Concierge |
| SignatureMD | L Catterton | Concierge |
| Medi Weight Loss | Audax Group | Weight Loss |
| Options Medical Weight Loss | Thurston Group | Weight Loss |
Recent Provider Services Transactions with Buyers Active in Longevity & Wellness
Physician Growth Partners (PGP) brings extensive experience advising businesses across the longevity and wellness sector, leveraging its work with adjacent provider services businesses (men’s health clinics, medical spas, women’s health clinics, cosmetic dermatology practices, and other related specialties) as well as its active engagements with standalone longevity and wellness groups. These businesses share many of the characteristics that buyers prioritize when evaluating longevity, concierge medicine, and wellness clinics, including recurring patient visits, cash-pay revenue models, and the ability to scale across providers and locations while maintaining high standards of care.
Importantly, many of the private equity firms actively pursuing investments in longevity and wellness are the same investors PGP has worked with across dozens of transactions in other provider services sectors. This gives PGP established relationships and firsthand knowledge of the investment firms and decision-makers behind these acquisitions, rather than simply relationships with their portfolio companies. By combining deep sector experience with direct access to the financial sponsors driving consolidation, PGP helps founders understand how buyers evaluate their businesses, position themselves to maximize value, and identify partners aligned with their long-term growth objectives and clinical priorities.
Why Are Longevity, Wellness, and Concierge Medicine Business Owners Exploring Partnerships?
For an independent longevity, wellness, or concierge medicine operator, growth can require significant investment in recruitment, marketing, technology, and clinical infrastructure before a new provider, location or service line becomes profitable. A capital or strategic partner can supply financial and operating resources to support that expansion, while allowing the founder to monetize a portion of the value already created.
The potential benefits extend beyond funding. A scaled organization may centralize finance, human resources, patient scheduling, and other support functions. For owners balancing clinical responsibilities with business management, centralized support functions can create more time to focus on patient care and strategic planning for growth.
Why Might 2026-2027 Be a Useful Time to Evaluate a Longevity, Wellness, or Concierge Medicine Sale?
•Opportunity to Build Scale. A partnership provides the ability to accelerate growth and build scale to take advantage of a hyper fragmented market
•First-Mover Advantage. There is significant white space to roll up and consolidate the market given how early on in the investment life cycle we are.
•Succession and Liquidity Planning. A partnership may create a pathway for founders to diversify personal wealth and transition responsibilities over time. Beginning that process before a physician’s retirement becomes imminent allows more time to prepare the practice and support patient continuity.
•Regulatory Uncertainty. PGP expects regulatory oversight to keep evolving, with tighter enforcement in some modalities and shifting rules in others. Operating within evolving regulatory frameworks will require greater investment in compliance, quality, and infrastructure, which scaled partners are often better positioned to provide.
There is no uniform peak window for owners across these segments. The most favorable time to evaluate a sale is when the practice can demonstrate attractive performance and a strong forward outlook on growth so that it can approach the market from a position of strength. For some founders, that may support a near-term process; for others, additional preparation may create a more compelling opportunity.
Owners should also weigh the risks buyers will underwrite. Discretionary consumer spending can soften in a downturn, capped patient panels make growth dependent on physician recruitment, and capital is becoming more selective: one industry tracker found that financings for longevity clinics declined in count from mid-2025 through mid-2026, even as total longevity funding grew.5 Businesses with durable retention and a clear compliance posture will be best positioned in that environment.
What Is PGP’s Perspective on Longevity, Wellness, and Concierge Medicine?
Longevity, wellness, and concierge medicine remain an attractive area within healthcare services as consumers increasingly seek personalized, proactive care. From an M&A perspective, practices that translate consumer demand for personalized, proactive care into recurring revenue, strong patient retention, and a repeatable growth model will be best positioned to attract capital and strategic partners. As the sector matures, clinical quality, regulatory compliance, and sustainable financial performance will become increasingly important differentiators in buyer evaluations.
Physician Growth Partners helps longevity, wellness, and concierge medicine founders navigate sale decisions and evaluate partnerships that align with their long-term goals. For founder-owned operators, the first step is understanding how buyers would evaluate the business today and identifying opportunities to strengthen its positioning. Developing a thoughtful plan before approaching the market can expand owners’ options and help maximize value
Interested in learning more about market insights, valuation trends, and strategic opportunities?
Speak to a Senior BankerSources & Citations
Physician Growth Partners · This content is provided for informational purposes only and does not constitute legal, financial, or investment advice. All transaction data sourced as cited. © 2026 Physician Growth Advisors, LLC. All rights reserved.
Latest Market Updates


Considering a healthcare transaction? Start with a confidential conversation.
"*" indicates required fields


